AI-based research identifies ZNF268 as a potential marker of prostate cancer progression, raising hopes for more accurate ...
Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") today announced that it was notified by its licensing partner, Changchun GeneScience Pharmaceutical Co., Ltd. ("GenSci"), that China's National ...
His Majesty King Charles III has access to an exclusive GP surgery inside Buckingham Palace but he has no need to use it ...
A new study by the Medical University of Vienna found that a specialized form of imaging could identify 91% of prostate ...
A legal stoush is brewing between the Prostate Cancer Foundation of Australia and the government after the charity lost its ...
Foresee Pharmaceuticals was notified by its licensing partner, Changchun GeneScience Pharmaceutical Co., Ltd. ("GenSci"), that China'sNational Medical Products Administration (NMPA) has approved the ...
Prostate cancer is the most common cancer among men in South Korea, and even after surgical removal of the prostate, one in ...
An artificial intelligence (AI) solution developed by DeepHealth, a subsidiary of RadNet, could help nearly one in five ...
The band shared the news of his death on social media.
healthdigest.com on MSN
Warning signs men should look out for to prevent heart problems later in life
men-health-warning-signs-in-increase-risk-of-heart-problems-erectile-dysfunction-urinary-tract-infections ...
The article explains the role of andrology and presents Pacific OneHealth’s clinic as a coordinated pathway for assessment ...
Coller AI Competition awards £100k to LanthaGen Bio LtdAward given for Responsible AI Inaugural Innovation Festival concludes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results